Wilmington Savings Fund Society, FSB
Position in ROIV — Roivant Sciences Ltd.
CIK 900974
WILMINGTON, DE
Position in ROIV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,698
New position
Shares Held
48
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#457
of 494 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $11,168,948 across 32 Biotechnology names. ROIV ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
108,446 | $6,080,566 | |
| 2 | ABSI |
Absci Corp
|
189,522 | $2,196,559 | |
| 3 | TECH |
BIO-TECHNE Corp
|
28,159 | $1,989,433 | |
| 4 | ARGX |
Argenx SE
|
239 | $221,736 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
370 | $183,789 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
393 | $146,066 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
106 | $66,095 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
1,633 | $60,763 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,698 | 48 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||